Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06501898 · ClinicalTrials.gov registry record · NA

Tributyrin: Time Course & Efficacy to Improve Health & Performance

A NA study, sponsored by Florida State University.

Terminated
Registry status
NA
Development phase
4
Enrollment target

NCT06501898 is a NA study that was terminated before completion, run by Florida State University. The registered enrollment target is 4 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06501898, a NA study, was terminated before completion, sponsored by Florida State University.

TERMINATED
Registry status
NA
Development phase
4 participants
Enrollment target

Study Summary

The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement through improving gut and immune health, sleep, and performance as well as reduce inflammation. Participants will supplement for tributyrin for 4 weeks and complete fecal metabolite measures, cardiovascular evaluation, sleep assessment, and exercise testing as well as provide blood samples.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT CoreBiome

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2024-08-19
Est. Completion 2025-03-01
Phase NA

Sponsor

Florida State University

219 total trials

What the Registry Record Tells You About NCT06501898

The ClinicalTrials.gov registry entry for NCT06501898 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT06501898 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06501898 about?

NCT06501898 is a clinical study titled "Tributyrin: Time Course & Efficacy to Improve Health & Performance". The purpose of this study is to determine if tributyrin supplementation improves metabolite concentrations, overall health biomarkers, and performance in sedentary men and women. The study would further understand the potential usage of tributyrin as a health and performance increasing supplement th...

What is the current status of trial NCT06501898?

This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2024-08-19. Estimated completion is 2025-03-01.

What interventions are being tested in trial NCT06501898?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), CoreBiome (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06501898?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.